Long ‐term risk of infection in patients with Crohn's disease on anti‐TNF treatment: A prospective single center cohort study in China

ConclusionsLong‐term use of infliximab in patients with Crohn's disease has a high risk of infectious complications. Failure of mucosal healing and concomitant systemic corticosteroids treatment are independent risk factors of infectious events during IFX maintenance therapy. Copyright © 2017 John Wiley & Sons, Ltd.

Source: Journal of Digestive Diseases - June 23, 2017 Category: Gastroenterology Authors: Yue Li, Hui Jun Shu, Hong Lu, Hong Yang, Ji Li, Bei Tan, Jiaming Qian Tags: Original article Source Type: research